Social Function and Autism Spectrum Disorder in Children and Adults with Neurofibromatosis Type 1: a Systematic Review and Meta-Analysis

被引:44
|
作者
Chisholm, Anita K. [1 ,2 ]
Anderson, Vicki A. [1 ,2 ]
Pride, Natalie A. [3 ]
Malarbi, Stephanie [1 ,2 ]
North, Kathryn N. [1 ,2 ]
Payne, Jonathan M. [1 ,2 ]
机构
[1] Royal Childrens Hosp, Murdoch Childrens Res Inst, Melbourne, Vic, Australia
[2] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia
[3] Childrens Hosp Westmead, Inst Neurosci & Muscle Res, Sydney, NSW, Australia
关键词
Neurofibromatosis type 1; Social function; Social perception; Social cognition; Autism spectrum disorder; QUALITY-OF-LIFE; EXECUTIVE FUNCTION; EMOTIONAL-PROBLEMS; ATTENTION; DEFICITS; ADOLESCENTS; PREVALENCE; TRAITS; SYMPTOMATOLOGY; BEHAVIOR;
D O I
10.1007/s11065-018-9380-x
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
In light of the proliferation of recent research into social function in neurofibromatosis type 1 (NF1), a systematic review and meta-analysis is required to synthesise data and place findings within the context of a theoretical framework. This paper reviews findings from research into social function and autism spectrum disorder (ASD) in children and adults with NF1 and integrates these findings with the Socio-Cognitive Integration Abilities Model (SOCIAL). It also critically appraises links between social outcomes, internal and external factors moderating social functioning, cognitive domains implicated in social functioning, and underlying neural pathology in NF1. A systematic literature search conducted in MedLine (Ovid), PsycINFO (Ovid), Embase (Ovid), and PubMed electronic databases yielded 35 papers that met inclusion criteria for the systematic review. Out of these papers, 22 papers provided sufficient data for meta-analysis. Findings from this review and meta-analysis provide evidence that children and adults with NF1 exhibit significantly higher prevalence and severity of social dysfunction and ASD symptomatology. To date, very few studies have examined social cognition in NF1 but results indicate the presence of both perceptual and higher-level impairments in this population. The results of this review also provide support for age, gender, and comorbid ADHD as moderating factors for social outcomes in NF1. Suggestions for future research are offered to further our understanding of the social phenotype in NF1 and to facilitate the development of targeted interventions.
引用
下载
收藏
页码:317 / 340
页数:24
相关论文
共 50 条
  • [21] Bone Health in Children and Youth with Autism Spectrum Disorder: A Systematic Review and Meta-Analysis
    Abadi, Mahdi Rostami Haji
    Kontulainen, Saija
    JOURNAL OF BONE AND MINERAL RESEARCH, 2020, 35 : 312 - 312
  • [22] Treatment Effect of Bumetanide in Children With Autism Spectrum Disorder: A Systematic Review and Meta-Analysis
    Wang, Tiantian
    Shan, Ling
    Miao, Chunyue
    Xu, Zhida
    Jia, Feiyong
    FRONTIERS IN PSYCHIATRY, 2021, 12
  • [23] Congenital Cytomegalovirus Infection in Children with Autism Spectrum Disorder: Systematic Review and Meta-Analysis
    Maeyama, Kaori
    Tomioka, Kazumi
    Nagase, Hiroaki
    Yoshioka, Mieko
    Takagi, Yasuko
    Kato, Takeshi
    Mizobuchi, Masami
    Kitayama, Shinji
    Takada, Satoshi
    Nagai, Masashi
    Sakakibara, Nana
    Nishiyama, Masahiro
    Taniguchi-Ikeda, Mariko
    Morioka, Ichiro
    Iijima, Kazumoto
    Nishimura, Noriyuki
    JOURNAL OF AUTISM AND DEVELOPMENTAL DISORDERS, 2018, 48 (05) : 1483 - 1491
  • [24] Congenital Cytomegalovirus Infection in Children with Autism Spectrum Disorder: Systematic Review and Meta-Analysis
    Kaori Maeyama
    Kazumi Tomioka
    Hiroaki Nagase
    Mieko Yoshioka
    Yasuko Takagi
    Takeshi Kato
    Masami Mizobuchi
    Shinji Kitayama
    Satoshi Takada
    Masashi Nagai
    Nana Sakakibara
    Masahiro Nishiyama
    Mariko Taniguchi-Ikeda
    Ichiro Morioka
    Kazumoto Iijima
    Noriyuki Nishimura
    Journal of Autism and Developmental Disorders, 2018, 48 : 1483 - 1491
  • [25] Impact of antipsychotics in children and adolescents with autism spectrum disorder: a systematic review and meta-analysis
    D'Alo, Gian Loreto
    De Crescenzo, Franco
    Amato, Laura
    Cruciani, Fabio
    Davoli, Marina
    Fulceri, Francesca
    Minozzi, Silvia
    Mitrova, Zuzana
    Morgano, Gian Paolo
    Nardocci, Franco
    Saulle, Rosella
    Schuenemann, Holger Jens
    Scattoni, Maria Luisa
    HEALTH AND QUALITY OF LIFE OUTCOMES, 2021, 19 (01)
  • [26] Effectiveness of music therapy in children with autism spectrum disorder: A systematic review and meta-analysis
    Ke, Xiaohua
    Song, Wei
    Yang, Minguang
    Li, Jianhong
    Liu, Weilin
    FRONTIERS IN PSYCHIATRY, 2022, 13
  • [27] Psychopathology in parents of children with autism spectrum disorder: A systematic review and meta-analysis of prevalence
    Schnabel, Alexandra
    Youssef, George J.
    Hallford, David J.
    Hartley, Eliza J.
    McGillivray, Jane A.
    Stewart, Michelle
    Forbes, David
    Austin, David W.
    AUTISM, 2020, 24 (01) : 26 - 40
  • [28] Impact of antipsychotics in children and adolescents with autism spectrum disorder: a systematic review and meta-analysis
    Gian Loreto D’Alò
    Franco De Crescenzo
    Laura Amato
    Fabio Cruciani
    Marina Davoli
    Francesca Fulceri
    Silvia Minozzi
    Zuzana Mitrova
    Gian Paolo Morgano
    Franco Nardocci
    Rosella Saulle
    Holger Jens Schünemann
    Maria Luisa Scattoni
    Health and Quality of Life Outcomes, 19
  • [29] Joint attention interventions for children with autism spectrum disorder: a systematic review and meta-analysis
    Murza, Kimberly A.
    Schwartz, Jamie B.
    Hahs-Vaughn, Debbie L.
    Nye, Chad
    INTERNATIONAL JOURNAL OF LANGUAGE & COMMUNICATION DISORDERS, 2016, 51 (03) : 236 - 251
  • [30] Sleep in adults with autism spectrum disorder and attention deficit/hyperactivity disorder: A systematic review and meta-analysis
    Lugo, Jorge
    Fadeuilhe, Christian
    Gisbert, Laura
    Setien, Imanol
    Delgado, Mercedes
    Corrales, Montserrat
    Richarte, Vanesa
    Ramos-Quiroga, Josep Antoni
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2020, 38 : 1 - 24